Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer Expands License to Entelos Software


Entelos said this week that Pfizer has taken a non-exclusive perpetual license to its Metabolism Physiolab platform.

Under the terms of the license, which expands on a previous agreement between the firms, Pfizer will have access to both Entelos’ PhysioLab Modeler software and its PhysioLab Simulation Server to study the biological mechanisms underlying disease.

Further details about the terms of the license were not disclosed.

The two companies announced a research partnership based on the Entelos Cardiovascular PhysioLab platform in 2007 following an earlier announcement that a subsidiary of Pfizer based in Ireland had agreed to purchase more than 2.5 million Entelos shares worth $1.5 million (BioInform 11/16/2007).

At the time of the original announcement, Entelos disclosed that the research would be focused on identifying biomarkers and interpreting clinical study data.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.